Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Analytical Biochemistry
|
March 10, 2001
Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists
M S Fahey, D Dawbarn, S J Allen, et al.
Brain Research
|
April 30, 1986
Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains
D Dawbarn, N Zamir, C M Waters, et al.
Neuroscience
|
January 19, 2010
Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis
R Pinto, B Frias, S Allen, et al.
Neuroscience Letters
|
September 30, 1991
Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus
S J Allen, S H MacGowan, J J Treanor, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatum
P C Emson, D Dawbarn, M N Rossor, et al.
Structure (London, England : 1993)
|
December 12, 2001
Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5
M J Banfield, R L Naylor, A G Robertson, et al.
The Journal of Comparative Neurology
|
November 22, 1989
Distribution of beta-nerve growth factor receptors in the human basal forebrain
S J Allen, D Dawbarn, M G Spillantini, et al.
Pain
|
January 30, 2007
Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat
T Bishop, D W Hewson, P K Yip, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Cloning and characterization of the presenilin-2 gene promoter
K R Pennypacker, R Fuldner, R Xu, et al.
Biochemical Society Transactions
|
July 22, 2006
NGF receptor TrkAd5: therapeutic agent and drug design target
D Dawbarn, M Fahey, J Watson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Analytical Biochemistry
|
March 10, 2001
Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists
M S Fahey, D Dawbarn, S J Allen, et al.
Brain Research
|
April 30, 1986
Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains
D Dawbarn, N Zamir, C M Waters, et al.
Neuroscience
|
January 19, 2010
Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis
R Pinto, B Frias, S Allen, et al.
Neuroscience Letters
|
September 30, 1991
Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus
S J Allen, S H MacGowan, J J Treanor, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatum
P C Emson, D Dawbarn, M N Rossor, et al.
Structure (London, England : 1993)
|
December 12, 2001
Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5
M J Banfield, R L Naylor, A G Robertson, et al.
The Journal of Comparative Neurology
|
November 22, 1989
Distribution of beta-nerve growth factor receptors in the human basal forebrain
S J Allen, D Dawbarn, M G Spillantini, et al.
Pain
|
January 30, 2007
Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat
T Bishop, D W Hewson, P K Yip, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Cloning and characterization of the presenilin-2 gene promoter
K R Pennypacker, R Fuldner, R Xu, et al.
Biochemical Society Transactions
|
July 22, 2006
NGF receptor TrkAd5: therapeutic agent and drug design target
D Dawbarn, M Fahey, J Watson, et al.
Page
of 5